Chiang Hoang-yung, manager of the Industrial Technology Information Service, says that at the present stage, genetically modified pharmaceutical products are made using bacteria, yeast, tissue culturing, or recombinant DNA technology. The proteins that microorganism secrete must be processed in order to get active proteins. Use of transgenic animals for production not only avoids this problem, but can increase production volume and lower costs.
生物技術中心經理江晃榮指出，現階段生技醫藥品是利用細菌、酵母菌、組織培養或重組ＤＮＡ技術來生產，由微生物所分泌的蛋白質必須經過處理才能獲得活性蛋白質，利用動物來生產則不但無此缺點，而且產能高、價位低。